Sutro biopharma to present at the td cowen 45th annual health care conference

South san francisco, calif., march 03, 2025 (globe newswire) -- sutro biopharma, inc. (sutro or the company) (nasdaq: stro), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (adcs), today announced that management will present at the td cowen 45th annual health care conference taking place march 3-5, 2025 in boston, ma.
COWN Ratings Summary
COWN Quant Ranking